1. Home
  2. OCGN vs PAMT Comparison

OCGN vs PAMT Comparison

Compare OCGN & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • PAMT
  • Stock Information
  • Founded
  • OCGN 2013
  • PAMT 1980
  • Country
  • OCGN United States
  • PAMT United States
  • Employees
  • OCGN N/A
  • PAMT N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • PAMT Trucking Freight/Courier Services
  • Sector
  • OCGN Health Care
  • PAMT Industrials
  • Exchange
  • OCGN Nasdaq
  • PAMT Nasdaq
  • Market Cap
  • OCGN 278.3M
  • PAMT 272.9M
  • IPO Year
  • OCGN N/A
  • PAMT 1985
  • Fundamental
  • Price
  • OCGN $1.03
  • PAMT $12.83
  • Analyst Decision
  • OCGN Strong Buy
  • PAMT Hold
  • Analyst Count
  • OCGN 3
  • PAMT 1
  • Target Price
  • OCGN $6.00
  • PAMT $12.50
  • AVG Volume (30 Days)
  • OCGN 8.5M
  • PAMT 13.9K
  • Earning Date
  • OCGN 08-07-2025
  • PAMT 07-23-2025
  • Dividend Yield
  • OCGN N/A
  • PAMT N/A
  • EPS Growth
  • OCGN N/A
  • PAMT N/A
  • EPS
  • OCGN N/A
  • PAMT N/A
  • Revenue
  • OCGN $4,522,000.00
  • PAMT $687,396,000.00
  • Revenue This Year
  • OCGN N/A
  • PAMT N/A
  • Revenue Next Year
  • OCGN N/A
  • PAMT $9.03
  • P/E Ratio
  • OCGN N/A
  • PAMT N/A
  • Revenue Growth
  • OCGN N/A
  • PAMT N/A
  • 52 Week Low
  • OCGN $0.52
  • PAMT $11.01
  • 52 Week High
  • OCGN $1.98
  • PAMT $23.70
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 55.00
  • PAMT N/A
  • Support Level
  • OCGN $0.95
  • PAMT N/A
  • Resistance Level
  • OCGN $1.15
  • PAMT N/A
  • Average True Range (ATR)
  • OCGN 0.11
  • PAMT 0.00
  • MACD
  • OCGN -0.02
  • PAMT 0.00
  • Stochastic Oscillator
  • OCGN 22.62
  • PAMT 0.00

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About PAMT PAMT CORP Common Stock

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

Share on Social Networks: